Orange Book product · Generic (ANDA)
OXACILLIN SODIUM
OXACILLIN SODIUM
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
OXACILLIN SODIUM
Strength
EQ 250MG BASE/5ML
Dosage form
FOR SOLUTION
Route
ORAL
TE code
Not listed
Application
ANDA 061457
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of OXACILLIN SODIUM
- 1989BACTOCILL IN PLASTIC CONTAINERBrand (NDA)
NDA 050640 · BAXTER HLTHCARE
- —PROSTAPHLINBrand (NDA)
NDA 050118 · APOTHECON
- —PROSTAPHLINBrand (NDA)
NDA 050194 · APOTHECON
- —OXACILLIN SODIUMBrand (NDA)
NDA 050195 · APOTHECON
- 2020OXACILLIN SODIUMGeneric (ANDA)
ANDA 206199 · FRESENIUS KABI USA
- 2020OXACILLIN SODIUMGeneric (ANDA)
ANDA 206198 · FRESENIUS KABI USA
- 2017OXACILLIN SODIUMGeneric (ANDA)
ANDA 207148 · WOCKHARDT BIO AG
- 2017OXACILLIN SODIUMGeneric (ANDA)
ANDA 206760 · PIRAMAL CRITICAL
- 2017OXACILLIN SODIUMGeneric (ANDA)
ANDA 206681 · PIRAMAL CRITICAL
- 2017OXACILLIN SODIUMGeneric (ANDA)
ANDA 207147 · WOCKHARDT BIO AG
- 2015OXACILLIN SODIUMGeneric (ANDA)
ANDA 203950 · HOSPIRA
- 2014OXACILLIN SODIUMGeneric (ANDA)
ANDA 091486 · ONESOURCE SPECIALTY
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
